CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17,464 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04097223
NCT04097223N/ACompleted

Real-world Treatment of Newly Diagnosed COPD Patients: A Retrospective German Claims Data Analysis

Boehringer Ingelheim·observational·Posted Sep 20, 2019·Updated Feb 24, 2022

In Brief

An observational study for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 17,464 participants across 1 site.

Detailed Summary

A retrospective analysis study in COPD patients for an exact follow-up period of 12 months (in subgroup analyses: 24 and 36 months); censoring of patients will only be done in case a patient died during the respective follow-up period.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 20, 2019
Enrollment StartNov 20, 2019
Primary CompletionJul 1, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.8 years ago